The World Parkinson Congress (WPC) gathers researchers, clinicians, and people living with Parkinson’s disease (PD) from around the world every three years. At the 7th WPC in Phoenix this May, several scientific themes surfaced again and again. Many questions remain open, but these themes show where PD research and care are headed. We’re sharing them for those who couldn’t attend. To see what APDA presented at the conference, read our recap of APDA’s initiatives at WPC 2026.
Seven Themes from World Parkinson Congress (WPC) 2026
Parkinson’s Disease is Many Diseases Rather Than One
One of the most consistent themes explored at WPC 2026 was that PD is not a single disorder with a single root cause. Many researchers are moving towards the idea that PD represents a collection of related diseases that may differ in their biological origins, progression, symptoms, and treatment responses.
There are many factors that can contribute to this diversity including the risk factors that contribute to disease. These risks include various genetic mutations and environmental exposures, and understanding how these risks affect the clinical manifestations of PD is a hot topic in research today. It suggests that the future of PD treatment may be individualized, a treatment approach known as precision medicine.
The Priority of Early Detection
Another recurring theme was the focus on prodromal PD which is the period before classic motor symptoms appear. Some of the early signs include:
- REM sleep behavior disorder
- Loss of smell
- Constipation
- Cognitive changes
A variety of new developments are in the pipeline to aid in early detection methods. New biomarkers, genetic testing, and more advanced imaging tools are being explored to help identify at-risk individuals earlier in the disease progression.
Earlier detection is paramount for managing symptoms and will be especially important when treatment options become available that are neuroprotective and prevent significant nerve cell loss.
Disease Modification Remains the Ultimate Goal
Currently, therapy options focus on symptom management rather than slowing or stopping disease progression. Throughout the conference, multiple researchers emphasized that developing disease-modifying therapies remains one of the highest priorities in PD research.
Some of the disease-modification topics covered at WPC included:
- Genetic driver identification and targeting (gene therapies)
- Novel combination therapies
- Alpha-synuclein-targeting therapies
- Mitochondrial and lysosomal dysfunction pathway therapies
Stem cell therapies are also a big area of discussion for PD, especially after encouraging findings from recent studies in Japan. A lot of these studies are still in the early and experimental stages, but they highlight the increasing efforts to move beyond symptom control and actually aim to address the underlying biology of the disease that may, one day, lead to slowing or stopping disease progression.
Exercise
Exercise was one of the most widely discussed topics throughout the conference. The evidence continues to substantiate that physical activity offers benefits that extend beyond mobility and quality of life. The big question that is still ongoing is: does exercise have neuroprotective effects that can influence PD progression?
Exercise is increasingly viewed as an essential component of treatment rather than simply an optional lifestyle recommendation. A variety of programs have been developed to incorporate routine exercise in patient treatment plans including but not limited to:
- Strength training
- Aerobic activities
- Balance training
- Skilled movement (e.g. boxing, dancing)
The scientific community is united in recognizing exercise as one of the most valuable tools currently and readily available to people living with PD today. (To learn more about exercising with PD, download Be Active & Beyond: A Guide to Exercise and Wellness for People With Parkinson’s Disease, also available in Spanish and Simplified Chinese.)
Non-motor Symptoms Are Receiving Greater Recognition
Many of the presentations at WPC continued to illustrate that PD affects much more than just movement. Some of these non-motor symptoms include:
- Sleep disturbances
- Cognitive changes
- Mood disorders
- Fatigue
- Pain
- Sexual dysfunction
- GI symptoms
These symptoms can substantially decrease quality of life if not assessed and treated adequately. The conference emphasized the need to treat the whole patient in order to have the greatest impact on quality of life.
Collaboration is Central to Progress
One distinctive aspect of WPC is the bringing together of a variety of professional backgrounds such as scientists, clinicians, and therapists with the people they aim to help — people with PD and their care partners. This is an important aspect of patient care as research priorities are being shaped by the actual experiences and concerns of people living with PD.
The knowledge of quality of life, caregiver challenges, communication, and real-world situations are essential in the development of treatments that fully encompass a patient’s needs. This is a vital aspect that will continue to move PD research towards a more patient-centered approach that combines biological discoveries with practical improvements in care.
The Future of PD Research
The overall takeaways from WPC 2026 suggest that PD research is entering a more personalized and multidisciplinary era. From earlier detection methods and precision medicine to regenerative therapies and greater attention to non-motor symptoms, the field continues to expand its understanding of what PD is and how it may eventually be treated.
With all the progress that has been made, there is still much to be done to further develop the discoveries made and presented this year. It will be exciting to see the updates to all these projects and more in the next WPC meeting (2029) in Quebec City, Canada.
Tips & Takeaways
- WPC is an important conference that brings together the latest in PD progress. Common scientific themes were apparent:
- PD is increasingly being viewed as multiple diseases rather than one
- Earlier detection may open the door for future interventions
- Disease-modifying therapies remain a major research priority
- Exercise continues to be one of the most powerful tools
- Non-motor symptoms deserve equal attention alongside motor symptoms
- Precision medicine and genetics are shaping future treatments
- Collaboration between researchers, clinicians, and patients is accelerating progress
- You can learn about some of the exciting posters we presented at WPC about our unique research funding and the impact of our community initiatives.
- You can start planning now to join us at the next WPC in Quebec City in 2029!
This blog was written by Clark Jones, PhD, and was reviewed, edited, and approved by Dr. Rebecca Gilbert.